Promising therapy for relapsing multibple sclerosis
Tuesday, February 16, 2010 - 13:42
in Health & Medicine
An international team of researchers has found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis. This new study was published online Feb. 16, 2010, and in the March edition of the Lancet Neurology.